AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAmadacycline methanesulfonate is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.
More Information Supplier PageAmadacycline methanesulfonate is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.
More Information Supplier PageAmadacycline methanesulfonate is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAMD-070 hydrochloride is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay, inhibit the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.
More Information Supplier PageAMD-070 hydrochloride is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay, inhibit the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.
More Information Supplier PageAMD-070 hydrochloride is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay, inhibit the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PageAmentoflavone inhibits vascularization of tumors by blocking the activity of angiogenic VEGFs.
More Information Supplier PageAmentoflavone inhibits vascularization of tumors by blocking the activity of angiogenic VEGFs.
More Information Supplier PageAmentoflavone inhibits vascularization of tumors by blocking the activity of angiogenic VEGFs.
More Information Supplier PageAmetantrone (AM) is a synthetic 9,10-anthracenedione bearing two (hydroxyethylamino)ethylamino residues at positions 1 and 4 along with other anthraquinones and anthracyclines.
More Information Supplier PageAmetantrone (AM) is a synthetic 9,10-anthracenedione bearing two (hydroxyethylamino)ethylamino residues at positions 1 and 4 along with other anthraquinones and anthracyclines.
More Information Supplier PageAmetantrone (AM) is a synthetic 9,10-anthracenedione bearing two (hydroxyethylamino)ethylamino residues at positions 1 and 4 along with other anthraquinones and anthracyclines.
More Information Supplier PageAmetantrone (AM) is a synthetic 9,10-anthracenedione bearing two (hydroxyethylamino)ethylamino residues at positions 1 and 4 along with other anthraquinones and anthracyclines.
More Information Supplier PageAmfebutamone (Bupropion) is an atypical antidepressant and smoking cessation aid.
More Information Supplier PageAmfebutamone (Bupropion) is an atypical antidepressant and smoking cessation aid.
More Information Supplier PageAmfebutamone (Bupropion) is an atypical antidepressant and smoking cessation aid.
More Information Supplier PageAmfebutamone (Bupropion) is an atypical antidepressant and smoking cessation aid.
More Information Supplier PageAmfebutamone (Bupropion) is an atypical antidepressant and smoking cessation aid.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG 208 is a novel c-Met inhibitor that inhibits the ligand-dependent and ligand-independent activation of c-Met, inhibiting its tyrosine kinase activity.
More Information Supplier PageAMG 208 is a novel c-Met inhibitor that inhibits the ligand-dependent and ligand-independent activation of c-Met, inhibiting its tyrosine kinase activity.
More Information Supplier PageAMG 208 is a novel c-Met inhibitor that inhibits the ligand-dependent and ligand-independent activation of c-Met, inhibiting its tyrosine kinase activity.
More Information Supplier PageAMG 208 is a novel c-Met inhibitor that inhibits the ligand-dependent and ligand-independent activation of c-Met, inhibiting its tyrosine kinase activity.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier PageAMG 900 is a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
More Information Supplier Page
